Skip to main content

Compare Stocks

Date Range: 

 Bio-Rad LaboratoriesAvantorWatersPerkinElmer
SymbolNYSE:BIONYSE:AVTRNYSE:WATNYSE:PKI
Price Information
Current Price$590.97$30.44$315.48$141.27
52 Week RangeBuyBuyHoldBuy
MarketRank™
Overall Score1.52.01.31.9
Analysis Score2.53.50.91.4
Community Score2.43.02.02.4
Dividend Score0.00.00.01.7
Ownership Score0.81.71.71.7
Earnings & Valuation Score1.91.91.92.5
Analyst Ratings
Consensus RecommendationBuyBuyHoldBuy
Consensus Price Target$700.00$34.87$251.25$141.73
% Upside from Price Target18.45% upside14.54% upside-20.36% downside0.32% upside
Trade Information
Market Cap$17.59 billion$17.72 billion$19.47 billion$15.83 billion
Beta0.831.840.971.19
Average Volume195,4234,424,104373,921991,463
Sales & Book Value
Annual Revenue$2.31 billion$6.04 billion$2.41 billion$2.88 billion
Price / Sales7.612.938.095.49
Cashflow$7.00 per share$1.97 per share$16.75 per share$5.85 per share
Price / Cash84.4215.4518.8424.16
Book Value$192.32 per share$2.55 per share($3.36) per share$25.33 per share
Price / Book3.0711.94-93.895.58
Profitability
Net Income$1.76 billion$37.80 million$592.20 million$227.56 million
EPS$7.06$0.58$8.99$4.10
Trailing P/E Ratio5.06253.6739.2938.39
Forward P/E Ratio57.9427.9335.5717.97
P/E GrowthN/A1.078.790.99
Net Margins147.91%2.21%22.61%12.74%
Return on Equity (ROE)3.77%44.58%-349.31%21.57%
Return on Assets (ROA)2.74%6.85%21.11%9.61%
Dividend
Annual PayoutN/AN/AN/A$0.28
Dividend YieldN/AN/AN/A0.20%
Three-Year Dividend GrowthN/AN/AN/AN/A
Payout RatioN/AN/AN/A6.83%
Years of Consecutive Dividend GrowthN/AN/AN/A1 Years
Debt
Debt-to-Equity RatioN/A3.27%N/A0.46%
Current Ratio2.36%2.02%1.82%1.35%
Quick Ratio1.71%1.38%1.33%0.96%
Ownership Information
Institutional Ownership Percentage63.03%84.79%91.80%89.44%
Insider Ownership Percentage27.50%1.90%1.50%0.62%
Miscellaneous
Employees8,00012,4007,40014,000
Shares Outstanding29.76 million582.14 million61.70 million112.06 million
Next Earnings Date7/29/2021 (Estimated)8/4/2021 (Estimated)7/27/2021 (Estimated)7/27/2021 (Estimated)
OptionableOptionableNot OptionableOptionableOptionable
SourceHeadline
PerkinElmer hits the checkbook again, this time doling out $260M for next-gen therapy bioservices firm - Endpoints NewsPerkinElmer hits the checkbook again, this time doling out $260M for next-gen therapy bioservices firm - Endpoints News
endpts.com - May 13 at 3:14 PM
PerkinElmer Expands Into Cell Biology With $260M Nexcelom Bioscience AcquisitionPerkinElmer Expands Into Cell Biology With $260M Nexcelom Bioscience Acquisition
finance.yahoo.com - May 13 at 3:14 PM
Preclinical Tomography System Market is set for Lucrative Growth | Top Companies – PerkinElmer, Bruker, Mediso – The Manomet Current - The Manomet CurrentPreclinical Tomography System Market is set for Lucrative Growth | Top Companies – PerkinElmer, Bruker, Mediso – The Manomet Current - The Manomet Current
manometcurrent.com - May 13 at 9:59 AM
PerkinElmer To Acquire Nexcelom Bioscience For $260M - Yahoo FinancePerkinElmer To Acquire Nexcelom Bioscience For $260M - Yahoo Finance
finance.yahoo.com - May 13 at 9:59 AM
PerkinElmer To Acquire Nexcelom Bioscience For $260MPerkinElmer To Acquire Nexcelom Bioscience For $260M
finance.yahoo.com - May 13 at 9:59 AM
Fracking Fluid Market and Ecosystem Assessment by Segmentation, Technology (Cuadrilla Resources , PerkinElmer , InTech , Hexion Fracline , More) – Test & Measurement - Test & MeasurementFracking Fluid Market and Ecosystem Assessment by Segmentation, Technology (Cuadrilla Resources , PerkinElmer , InTech , Hexion Fracline , More) – Test & Measurement - Test & Measurement
testmeasurement.com.au - May 12 at 10:48 PM
PerkinElmer Expands Cell Biology Leadership with Agreement to Acquire Nexcelom Bioscience - Business WirePerkinElmer Expands Cell Biology Leadership with Agreement to Acquire Nexcelom Bioscience - Business Wire
businesswire.com - May 12 at 5:47 PM
PerkinElmer Expands Cell Biology Leadership with Agreement to Acquire Nexcelom BiosciencePerkinElmer Expands Cell Biology Leadership with Agreement to Acquire Nexcelom Bioscience
finance.yahoo.com - May 12 at 5:47 PM
Immunofluorescence Assay Analyzers Market 2021 Overview – PerkinElmer, BioMerieux, Inova Diagnostics, Getein Biotech – The Shotcaller - The ShotcallerImmunofluorescence Assay Analyzers Market 2021 Overview – PerkinElmer, BioMerieux, Inova Diagnostics, Getein Biotech – The Shotcaller - The Shotcaller
theshotcaller.net - May 12 at 12:47 PM
Automated Workstations Market including top key players Tecan Group, PerkinElmer, Danaher, Thermo Fisher, Agilent Technologies – The Manomet Current - The Manomet CurrentAutomated Workstations Market including top key players Tecan Group, PerkinElmer, Danaher, Thermo Fisher, Agilent Technologies – The Manomet Current - The Manomet Current
manometcurrent.com - May 11 at 3:50 PM
Metagenomics Market 2021 Precise Outlook – Illumina, Inc., QIAGEN, Novogene Co., Ltd., PerkinElmer Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific – The Shotcaller - The ShotcallerMetagenomics Market 2021 Precise Outlook – Illumina, Inc., QIAGEN, Novogene Co., Ltd., PerkinElmer Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific – The Shotcaller - The Shotcaller
theshotcaller.net - May 11 at 10:50 AM
Oxford Immunotec’s T-SPOT.COVID Test is Used in the COV-AD Clinical Study to Investigate the Immunological Response to SARS-CoV-2 Infection in Patients with Primary and Secondary Antibody DeficiencyOxford Immunotec’s T-SPOT.COVID Test is Used in the COV-AD Clinical Study to Investigate the Immunological Response to SARS-CoV-2 Infection in Patients with Primary and Secondary Antibody Deficiency
finance.yahoo.com - May 11 at 10:50 AM
PerkinElmer (NYSE:PKI) Updates FY 2021 Earnings GuidancePerkinElmer (NYSE:PKI) Updates FY 2021 Earnings Guidance
americanbankingnews.com - May 11 at 8:10 AM
Graphite Tubes Consumables Market Therapeutic Growth Analysis by – PerkinElmer, Agilent, Shimadzu, Buck Scientific, Analytic Jena – The Shotcaller - The ShotcallerGraphite Tubes Consumables Market Therapeutic Growth Analysis by – PerkinElmer, Agilent, Shimadzu, Buck Scientific, Analytic Jena – The Shotcaller - The Shotcaller
theshotcaller.net - May 10 at 2:27 PM
GC Injector Liners Market Share Acquire Sluggish Growth in Upcoming Years : PerkinElmer, Restek Corporation, Thermo Scientific, Merck, Agilent – The Shotcaller - The ShotcallerGC Injector Liners Market Share Acquire Sluggish Growth in Upcoming Years : PerkinElmer, Restek Corporation, Thermo Scientific, Merck, Agilent – The Shotcaller - The Shotcaller
theshotcaller.net - May 10 at 9:26 AM
What Is PerkinElmer, Inc.s (NYSE:PKI) Share Price Doing?What Is PerkinElmer, Inc.'s (NYSE:PKI) Share Price Doing?
finance.yahoo.com - May 7 at 6:07 PM
PerkinElmer, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - NasdaqPerkinElmer, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - Nasdaq
nasdaq.com - May 7 at 1:06 PM
PerkinElmer (PKI) Moves 6.9% Higher: Will This Strength Last? - NasdaqPerkinElmer (PKI) Moves 6.9% Higher: Will This Strength Last? - Nasdaq
nasdaq.com - May 7 at 8:05 AM
Worldwide Laboratory Automation Industry to 2026 - Featuring Danaher, PerkinElmer and Thermo Fisher Among Others - Yahoo FinanceWorldwide Laboratory Automation Industry to 2026 - Featuring Danaher, PerkinElmer and Thermo Fisher Among Others - Yahoo Finance
finance.yahoo.com - May 7 at 8:05 AM
PerkinElmer - Consensus Indicates Potential 17.8% Upside - DirectorsTalk InterviewsPerkinElmer - Consensus Indicates Potential 17.8% Upside - DirectorsTalk Interviews
directorstalkinterviews.com - May 7 at 8:05 AM
Worldwide Laboratory Automation Industry to 2026 - Featuring Danaher, PerkinElmer and Thermo Fisher Among Others - WFMZ AllentownWorldwide Laboratory Automation Industry to 2026 - Featuring Danaher, PerkinElmer and Thermo Fisher Among Others - WFMZ Allentown
wfmz.com - May 6 at 10:03 PM
PerkinElmer to Donate 1 Million Rapid COVID-19 Antigen Tests to Combat the Pandemics Second Wave in India - Business Wire IndiaPerkinElmer to Donate 1 Million Rapid COVID-19 Antigen Tests to Combat the Pandemic's Second Wave in India - Business Wire India
businesswireindia.com - May 6 at 4:58 PM
PerkinElmer to distribute 1 M COVID-19 antigen tests in 10 states - BSI bureauPerkinElmer to distribute 1 M COVID-19 antigen tests in 10 states - BSI bureau
biospectrumindia.com - May 6 at 11:58 AM
PerkinElmer: Q1 Earnings Snapshot - CT PostPerkinElmer: Q1 Earnings Snapshot - CT Post
ctpost.com - May 6 at 11:58 AM
PerkinElmer Stock Shows Every Sign Of Being Fairly Valued - Yahoo FinancePerkinElmer Stock Shows Every Sign Of Being Fairly Valued - Yahoo Finance
finance.yahoo.com - May 6 at 11:58 AM
3 Large Cap Growth Stocks Set for a Strong 2021 (PKI)3 Large Cap Growth Stocks Set for a Strong 2021 (PKI)
marketbeat.com - January 7 at 12:21 PM
DateCompanyBrokerageAction
2/12/2021Bio-Rad LaboratoriesCitigroupBoost Price Target
2/5/2021Bio-Rad LaboratoriesJefferies Financial GroupBoost Price Target
10/30/2020Bio-Rad LaboratoriesSmith Barney CitigroupBoost Price Target
10/30/2020Bio-Rad LaboratoriesWells Fargo & CompanyBoost Price Target
3/26/2020Bio-Rad LaboratoriesBarclaysLower Price Target
8/20/2019Bio-Rad LaboratoriesThe Goldman Sachs GroupUpgrade
5/9/2019Bio-Rad LaboratoriesDeutsche Bank AktiengesellschaftBoost Price Target
5/5/2021AvantorStifel NicolausUpgrade
5/5/2021AvantorRaymond JamesBoost Price Target
5/5/2021AvantorMorgan StanleyBoost Price Target
5/5/2021AvantorCredit Suisse GroupBoost Price Target
4/29/2021AvantorJPMorgan Chase & Co.Boost Price Target
4/29/2021AvantorRobert W. BairdBoost Price Target
4/29/2021AvantorPiper SandlerBoost Price Target
1/19/2021AvantorKeyCorpBoost Price Target
12/16/2020AvantorCitigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellBoost Price Target
5/12/2021WatersSVB LeerinkBoost Price Target
12/17/2020WatersCleveland ResearchUpgrade
7/28/2020WatersNeedham & Company LLCInitiated Coverage
4/29/2020WatersBank of AmericaLower Price Target
8/10/2020PerkinElmerBMO Capital MarketsBoost Price Target
7/29/2020PerkinElmerCfraUpgrade
5/7/2020PerkinElmerUBS GroupBoost Price Target
(Data available from 5/14/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.